The Recall Desk
HighFDA (Drugs)·D-0242-2026·Announced 2025-12-31

Posaconazole oral suspension recalled over potential metal particulates in the product

Merck Sharp & Dohme is recalling 845 kits of Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension over the potential presence of metal particulates.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Scored 3 under the risk-of-harm criterion: metal particulates in an oral medicine are a stated physical contaminant, and no injuries are reported.

Plain-English summary

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, manufactured by N.V. Organon of Oss, the Netherlands for Merck Sharp & Dohme LLC of Rahway, New Jersey, is being recalled.

The reason given in the enforcement record is the presence of particulate matter: the potential presence of metal particulates in the product.

The recall covers 845 kits from lots Z012339, Z010344, Z009908 and Z009909, all with an expiry date of 12-31-2026. Distribution was nationwide in the USA. The FDA has classified the action as Class II.

Patients should not stop taking a prescribed medicine without speaking to their prescriber or pharmacist, who can confirm whether a specific kit is affected and arrange a replacement.

The recalled product

Product
NOXAFIL (POSACONAZOLE)
Brand
NOXAFIL
Manufacturer
Merck Sharp & Dohme LLC
Hazard
  • particulate-matter
  • metal-particulates
  • contamination

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Lot#: Z012339
  • Z010344
  • Z009908
  • Z009909
  • Exp Date 12-31-2026

UPCs (1)

  • 0300854324025

Distribution

Distributed nationwide across the United States.